George Perry Selected Research

Gonadotropin-Releasing Hormone (GnRH)

1/2018	Putative Gonadotropin-Releasing Hormone Agonist Therapy and Dementia: An Application of Medicare Hospitalization Claims Data.
4/2006	Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice.
1/2006	The estrogen myth: potential use of gonadotropin-releasing hormone agonists for the treatment of Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

George Perry Research Topics

Disease

265	Alzheimer Disease (Alzheimer's Disease) 03/2024 - 01/2002
63	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2023 - 01/2002
48	Amyloid Plaque 03/2024 - 01/2002
34	Parkinson Disease (Parkinson's Disease) 03/2024 - 03/2002
28	Dementia (Dementias) 11/2023 - 01/2002
22	Cognitive Dysfunction 03/2024 - 05/2004
13	Mitochondrial Diseases (Mitochondrial Disease) 01/2020 - 05/2002
13	Neuroblastoma 01/2019 - 03/2002
11	Inflammation (Inflammations) 08/2023 - 10/2005
10	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2023 - 03/2002
9	Disease Progression 12/2023 - 10/2004
9	Neoplasms (Cancer) 10/2023 - 07/2003
9	Tauopathies 01/2020 - 03/2002
8	Prion Diseases (Transmissible Spongiform Encephalopathies) 08/2010 - 04/2002
7	Hypoxia (Hypoxemia) 01/2010 - 01/2003
6	Stroke (Strokes) 01/2023 - 01/2002
6	Nervous System Diseases (Neurological Disorders) 01/2020 - 10/2006
5	Neuroinflammatory Diseases 03/2024 - 12/2009
5	Frontotemporal Dementia (Semantic Dementia) 12/2023 - 04/2008
4	Lewy Body Disease (Lewy Body Dementia) 01/2017 - 07/2009
3	Atrophy 04/2023 - 04/2007
3	Encephalitis (Encephalitis, Rasmussen) 01/2023 - 09/2003
3	Chronic Disease (Chronic Diseases) 01/2017 - 05/2009
3	Iron Overload 12/2016 - 09/2005
3	Hemorrhage 01/2016 - 11/2002
3	Infections 11/2013 - 05/2004
3	Pathologic Processes 02/2010 - 09/2002

Drug/Important Bio-Agent (IBA)

57	Amyloid beta-PeptidesIBA 01/2023 - 01/2002
56	Amyloid (Amyloid Fibrils)IBA 03/2024 - 07/2002
53	Proteins (Proteins, Gene)FDA Link 04/2023 - 01/2002
31	MetalsIBA 03/2024 - 01/2002
28	IronIBA 03/2024 - 01/2002
25	AntioxidantsIBA 01/2020 - 02/2002
23	tau Proteins (tau Protein)IBA 01/2024 - 03/2002
16	Peptides (Polypeptides)IBA 11/2023 - 04/2002
13	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021 - 01/2002
13	Estrogens (Estrogen)FDA Link 01/2018 - 07/2003
13	Nucleic AcidsIBA 01/2018 - 03/2002
13	Free RadicalsIBA 01/2010 - 04/2002
12	RNA (Ribonucleic Acid)IBA 08/2023 - 03/2002
11	EnzymesIBA 01/2018 - 03/2003
10	GonadotropinsIBA 01/2018 - 11/2002
10	CopperIBA 12/2016 - 01/2002
9	Luteinizing Hormone (Lutropin)FDA LinkGeneric 12/2007 - 11/2002
8	LipidsIBA 03/2024 - 01/2005
7	AntibodiesIBA 01/2023 - 03/2005
7	Phosphotransferases (Kinase)IBA 01/2019 - 08/2006
7	Heme (Haem)IBA 01/2016 - 03/2003
7	Amyloid beta-Protein Precursor (Amyloid Protein Precursor)IBA 01/2010 - 09/2002
7	Heme Oxygenase-1IBA 01/2010 - 03/2003
7	Chelating AgentsIBA 01/2010 - 03/2003
6	Biomarkers (Surrogate Marker)IBA 07/2023 - 01/2010
6	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 10/2005
6	SteroidsIBA 01/2018 - 01/2004
6	Hormones (Hormone)IBA 09/2017 - 01/2004
6	Oxidants (Oxidizing Agents)IBA 12/2009 - 02/2002
5	DNA (Deoxyribonucleic Acid)IBA 08/2023 - 03/2002
5	Protein AggregatesIBA 08/2023 - 10/2003
5	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2020 - 02/2008
5	CholesterolIBA 01/2019 - 07/2002
5	Mitogen-Activated Protein KinasesIBA 01/2019 - 09/2002
5	Insulin (Novolin)FDA Link 12/2012 - 02/2005
5	Prion ProteinsIBA 01/2012 - 05/2004
4	lecanemabIBA 03/2024 - 01/2023
4	DNA-Binding Proteins (DNA Binding Protein)IBA 12/2023 - 02/2018
4	Neurotransmitter Agents (Neurotransmitter)IBA 08/2023 - 10/2005
4	Apolipoproteins E (ApoE)IBA 10/2021 - 01/2012
4	Neuroprotective AgentsIBA 01/2020 - 01/2010
4	SynucleinsIBA 12/2019 - 01/2011
4	Cholinergic Agents (Cholinergics)IBA 01/2019 - 04/2008
4	Leucine (L-Leucine)FDA Link 01/2018 - 11/2006
4	LeptinIBA 07/2015 - 01/2009
4	IonsIBA 08/2012 - 07/2002
4	8-hydroxyguanosineIBA 03/2012 - 11/2002
4	Amyloidogenic ProteinsIBA 01/2012 - 01/2004
4	Advanced Glycation End ProductsIBA 01/2012 - 05/2002
4	Peptide Hydrolases (Proteases)FDA Link 08/2010 - 07/2002
4	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 06/2008 - 03/2003
3	Trace Elements (Biometals)IBA 03/2024 - 07/2018
3	CalciumIBA 03/2024 - 07/2018
3	Coloring Agents (Dyes)IBA 03/2024 - 01/2007
3	VaccinesIBA 01/2023 - 07/2017
3	aducanumabIBA 01/2023 - 01/2022
3	ParaffinIBA 12/2020 - 07/2010
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2018 - 01/2006
3	Leuprolide (Lupron)FDA LinkGeneric 01/2018 - 04/2006
3	SugarsIBA 12/2017 - 01/2005
3	Transcription Factors (Transcription Factor)IBA 09/2017 - 10/2009
3	AutoantibodiesIBA 04/2016 - 02/2010
3	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2015 - 09/2005
3	Mitochondrial DNA (mtDNA)IBA 06/2013 - 03/2003
3	NucleosidesIBA 03/2012 - 11/2002
3	Memantine (Namenda)FDA Link 02/2010 - 09/2005
3	PresenilinsIBA 01/2010 - 10/2005
3	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 09/2009 - 03/2003

Therapy/Procedure

39	Therapeutics 03/2024 - 04/2002
6	Immunotherapy 08/2023 - 09/2003
4	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2018 - 08/2004
3	Synchrotrons 03/2024 - 07/2018
3	Lasers (Laser) 02/2018 - 03/2016